Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl R Alving

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Biochemical and Biophysical Research Communications|November 3, 2010
Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokinesGary R Matyas, Lindsay Wieczorek, Divya Bansal, et al.
Analytical and Bioanalytical Chemistry|December 18, 2015
A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuseOscar B Torres, Joshua F G Antoline, Fuying Li, et al.
Clinical and Vaccine Immunology : CVI|November 18, 2011
Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain sporesKristina K Peachman, Qin Li, Gary R Matyas, et al.
Plos One|August 11, 2012
HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responsesNicholas J Steers, Silvia Ratto-Kim, Mark S de Souza, et al.
Analytical and Bioanalytical Chemistry|April 21, 2018
A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioidsOscar B Torres, Alexander J Duval, Agnieszka Sulima, et al.
The Open Vaccine Journal|September 28, 2011
Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in RabbitsQin Li, Kristina K Peachman, Laurie Sower, et al.
Vaccine|May 6, 2014
Designing the epitope flanking regions for optimal generation of CTL epitopesNicholas J Steers, Jeffrey R Currier, Ousman Jobe, et al.
The Journal of Infectious Diseases|June 13, 2018
Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in HumansMangala Rao, Sayali Onkar, Kristina K Peachman, et al.
NPJ Vaccines|December 22, 2017
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvantOscar B Torres, Gary R Matyas, Mangala Rao, et al.
Vaccine|December 1, 2010
Highly effective generic adjuvant systems for orphan or poverty-related vaccinesMangala Rao, Kristina K Peachman, Qin Li, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Biochemical and Biophysical Research Communications|November 3, 2010
Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokinesGary R Matyas, Lindsay Wieczorek, Divya Bansal, et al.
Analytical and Bioanalytical Chemistry|December 18, 2015
A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuseOscar B Torres, Joshua F G Antoline, Fuying Li, et al.
Clinical and Vaccine Immunology : CVI|November 18, 2011
Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain sporesKristina K Peachman, Qin Li, Gary R Matyas, et al.
Plos One|August 11, 2012
HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responsesNicholas J Steers, Silvia Ratto-Kim, Mark S de Souza, et al.
Analytical and Bioanalytical Chemistry|April 21, 2018
A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioidsOscar B Torres, Alexander J Duval, Agnieszka Sulima, et al.
The Open Vaccine Journal|September 28, 2011
Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in RabbitsQin Li, Kristina K Peachman, Laurie Sower, et al.
Vaccine|May 6, 2014
Designing the epitope flanking regions for optimal generation of CTL epitopesNicholas J Steers, Jeffrey R Currier, Ousman Jobe, et al.
The Journal of Infectious Diseases|June 13, 2018
Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in HumansMangala Rao, Sayali Onkar, Kristina K Peachman, et al.
NPJ Vaccines|December 22, 2017
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvantOscar B Torres, Gary R Matyas, Mangala Rao, et al.
Vaccine|December 1, 2010
Highly effective generic adjuvant systems for orphan or poverty-related vaccinesMangala Rao, Kristina K Peachman, Qin Li, et al.
Pageof 11